WO2008045009A3 - Pharmaceutical dosage form - Google Patents

Pharmaceutical dosage form Download PDF

Info

Publication number
WO2008045009A3
WO2008045009A3 PCT/TR2007/000121 TR2007000121W WO2008045009A3 WO 2008045009 A3 WO2008045009 A3 WO 2008045009A3 TR 2007000121 W TR2007000121 W TR 2007000121W WO 2008045009 A3 WO2008045009 A3 WO 2008045009A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage form
coating
pharmaceutical dosage
core tablet
active ingredient
Prior art date
Application number
PCT/TR2007/000121
Other languages
French (fr)
Other versions
WO2008045009A2 (en
Inventor
Abdullah Uslu
Original Assignee
Nobel Ilac San Ve Tic A S
Abdullah Uslu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobel Ilac San Ve Tic A S, Abdullah Uslu filed Critical Nobel Ilac San Ve Tic A S
Priority to EP07852324A priority Critical patent/EP2086517A2/en
Publication of WO2008045009A2 publication Critical patent/WO2008045009A2/en
Publication of WO2008045009A3 publication Critical patent/WO2008045009A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention including pantoprazole active ingredient consists of pharmaceutical solid dosage form core tablet, an enteric-coating and a pre-coating between core tablet and enteric coating. Core tablet, contains the pantoprazole active ingredient together with sodium carboxymethylcellulose as binder and isomalt as filler.
PCT/TR2007/000121 2006-10-10 2007-10-10 Pharmaceutical dosage form WO2008045009A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07852324A EP2086517A2 (en) 2006-10-10 2007-10-10 Pharmaceutical dosage form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2006/05624 2006-10-10
TR2006/05624A TR200605624A2 (en) 2006-10-10 2006-10-10 Pharmaceutical dosage form

Publications (2)

Publication Number Publication Date
WO2008045009A2 WO2008045009A2 (en) 2008-04-17
WO2008045009A3 true WO2008045009A3 (en) 2008-12-31

Family

ID=39283297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2007/000121 WO2008045009A2 (en) 2006-10-10 2007-10-10 Pharmaceutical dosage form

Country Status (3)

Country Link
EP (1) EP2086517A2 (en)
TR (1) TR200605624A2 (en)
WO (1) WO2008045009A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105380919A (en) * 2015-11-20 2016-03-09 世贸天阶制药（江苏）有限责任公司 Pantoprazole sodium enteric-coated tablet and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001624A1 (en) * 1994-07-08 1996-01-25 Astra Aktiebolag Multiple unit pharmaceutical preparation containing proton pump inhibitor
DE19752843A1 (en) * 1997-11-28 1999-07-01 Byk Gulden Lomberg Chem Fab Pantoprazole and omeprazole film tablet and pellet used for treating conditions associated with elevated gastric acid secretion
EP1257256A1 (en) * 2000-02-17 2002-11-20 Alpharma APS Drug carrier pellet production process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001624A1 (en) * 1994-07-08 1996-01-25 Astra Aktiebolag Multiple unit pharmaceutical preparation containing proton pump inhibitor
DE19752843A1 (en) * 1997-11-28 1999-07-01 Byk Gulden Lomberg Chem Fab Pantoprazole and omeprazole film tablet and pellet used for treating conditions associated with elevated gastric acid secretion
EP1257256A1 (en) * 2000-02-17 2002-11-20 Alpharma APS Drug carrier pellet production process

Also Published As

Publication number Publication date
EP2086517A2 (en) 2009-08-12
TR200605624A2 (en) 2008-05-21
WO2008045009A2 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
WO2012085657A3 (en) Tamper resistant solid oral dosage forms
WO2009117130A3 (en) Extended release forumulation containing a wax
EP2081550A4 (en) Coating capsules with active pharmaceutical ingredients
IL194290A (en) Rna complex comprising a core double stranded region, a pharmaceutical compound comprising the same, a methof for preparing the same and uses thereof
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
EP1971655A4 (en) Uv-curable aqueous emulsion, preparation thereof and solventless coating compostion comprising the same
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
IL233677A (en) Substituted benzisoxazole aminopyrazolo-pyrimidine compounds, pharmaceutical compositions comprising them and use of the compounds for the manufacture of medicaments
PT2040755E (en) Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
WO2009059701A3 (en) Sustained release tablets with hydromorphone
WO2012022919A3 (en) Nalbuphine-based formulations and uses thereof
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
WO2011005052A8 (en) Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
WO2009019477A3 (en) Coating
EP2167490A4 (en) Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
BRPI0720314A2 (en) COMPOSITION, AND, USES OF A Triazole COMPOSITION AND COMPOSITION.
WO2011107944A3 (en) Modified release dosage form
WO2009135951A3 (en) Process for preparing a tablet comprising metformin
WO2007141743A3 (en) A tablet dosage form comprising cetirizine and pseudoephedrine
WO2010018175A3 (en) Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
WO2008045009A3 (en) Pharmaceutical dosage form
WO2009087657A3 (en) Stable pharmaceutical composition of duloxetine and process for its preparation
WO2009006299A3 (en) Multi-particulate systems
WO2009133455A3 (en) Pharmaceutical composition of clodipogrel
WO2009150238A3 (en) Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007852324

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07852324

Country of ref document: EP

Kind code of ref document: A2